A Study of Patient Reported Outcomes and Use of Self-Efficacy in the Management of Chronic Fibrotic Interstitial Lung Disease

Overview

About this study

Chronic fibrosing interstitial lung disease has significant negative impact on functional status and quality of life through often progressive and debilitating symptom burden. Prior studies have used various surveillance tools for assessing patient reported parameters and attested to the utility of these measurements for directing therapy and predicting outcome. We hypothesize that directed prospective measurements of such physiologic, emotional, and psychologic domains may correlate with baseline or presenting functional parameter and be incorporated into disease progression or staging models, perhaps capable of predicting outcomes as well as be targets of directed medical and non-medical therapies.  

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Adult patients with fibrotic interstitial lung disease (defined by the presence of fibrosis on chest computed tomography (CT)) and evidence of disease progression based on worsening reported symptom burden, decline in forced vital capacity, or degree of radiologic scarring.
  • Patients with emphysema but present fibrosis are also included.

Exclusion Criteria:

  • Stable or unchanged lung fibrosis (post-inflammatory, radiation induced), non-fibrotic ILD (organizing pneumonia), or non-ILD but chronic lung disease (severe asthma, COPD).

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Teng Moua, M.D.

Closed for enrollment

Contact information:

Teng Moua M.D.

(608) 263-7500

Moua.Teng@mayo.edu

More information

Publications

Publications are currently not available